IMAGINE
where you can go with ZILBRYSQ for GENERALIZED MYASTHENIA GRAVIS (gMG)

 

Discover the first FDA-approved, self-administered treatment for adults with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive.

See ZILBRYSQ Results

Significantly improves gMG symptoms

In a clinical trial, people taking ZILBRYSQ experienced significant improvements in activities of daily living as measured by MG-ADL.*

SEE TRIAL RESULTS

Rapid improvements in daily living

In the 12-week clinical trial, patients taking ZILBRYSQ experienced significant improvement in activities of daily living such as breathing, talking, swallowing, and being able to rise from a chair.*

Some patients also saw improvements in gMG symptoms as early as Week 1.

VIEW RESULTS

gMG treatment in your hands

ZILBRYSQ is self-administered and can be injected in seconds, at home or on the go.

HOW TO TAKE ZILBRYSQ

MG-ADL=Myasthenia Gravis Activities of Daily Living.

*Individual results may vary, and not all people will experience improvements.

As determined by improvement in the Myasthenia Gravis Activities of Daily Living (MG-ADL) score from baseline on Week 12 of the study; -4.4 points in the ZILBRYSQ-treated group (86 people) vs -2.3 in the placebo group (88 people). Individual results may vary, and not all people taking ZILBRYSQ will experience improvements.

ONWARD® PERSONALIZED SUPPORT DESIGNED TO MOVE YOU FORWARD.

Here for you throughout your treatment

ONWARD™ provides personalized support, including financial options, tools to help you track your symptoms, refresher injection coaching, and guidance when starting and continuing treatment.

Learn More

ONWARD is provided as a service of UCB and is intended to support the appropriate use of UCB medicines. ONWARD may be amended or canceled at any time without notice. Some program and eligibility restrictions may apply.